Hypofractionated Stereotactic Radiotherapy for the Treatment of Benign Intracranial Meningiomas: Long-Term Safety and Efficacy

CONCLUSIONS: Based on our data, hSRT remains an effective modality to treat low-grade ICMs with acceptable long-term toxicity and radionecrosis rates. hSRT should be offered to patients who are not ideal candidates for SRS while preserving the benefits of hypofractionation.PMID:34590613 | PMC:PMC8482200 | DOI:10.3390/curroncol28050314

Source: Current Oncology - September 30, 2021 Category: Cancer & Oncology Authors: Eric K Nguyen Gregory R Pond Jeffrey N Greenspoon Anthony C Whitton Crystal Hann Source Type: research